| Patents for C40B 30 - Methods of screening libraries (11,320) |
|---|
| 02/14/2013 | US20130040844 Biomarkers of aging for detection and treatment of disorders |
| 02/14/2013 | US20130040843 Increasing Multiplex Level by Externalization of Passive Reference in PCR Reactions |
| 02/14/2013 | US20130040842 Methods And Compositions For Phototransfer |
| 02/14/2013 | US20130040841 Digital assays with multiplexed detection of two or more targets in the same optical channel |
| 02/14/2013 | US20130040840 Nucleic acid amplification with integrated multiplex detection |
| 02/14/2013 | US20130040839 Method for Diagnosing or Determining the Prognosis of Colorectal Cancer (CRC) Using Novel Autoantigens: Gene Expression Guided Autoantigen Discovery |
| 02/14/2013 | US20130040838 Methods for identifying the presence of a bicuspid aortic valve |
| 02/14/2013 | US20130040837 Aptamer cell compositions |
| 02/14/2013 | US20130040836 Methods for engineering t-cell receptors |
| 02/14/2013 | US20130040835 Genes predictive of anti-TNF response in inflammatory diseases |
| 02/14/2013 | US20130040834 Sample plate systems and methods |
| 02/14/2013 | US20130040833 Use of microvesicles in analyzing nucleic acid profiles |
| 02/14/2013 | US20130040832 Identifying viral cell tropism |
| 02/14/2013 | US20130040831 Predicting Response to Anti-CD40 Therapy in DLBCL Patients |
| 02/14/2013 | US20130040830 Fluid Sample Testing System |
| 02/14/2013 | US20130040829 In vitro model of latent mycobacterial infection |
| 02/14/2013 | US20130040825 Dna damage detection assay and method |
| 02/14/2013 | US20130040824 Detection of genetic or molecular aberrations associated with cancer |
| 02/14/2013 | US20130039927 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies |
| 02/14/2013 | US20130039908 Prognostic markers and methods for prostate cancer |
| 02/14/2013 | US20130039887 Methods of Identifying and Using Anti-Viral Compounds |
| 02/14/2013 | US20130039856 Products and Methods |
| 02/14/2013 | CA2844671A1 Biomarker compositions and methods |
| 02/14/2013 | CA2838562A1 Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof |
| 02/12/2013 | US8372949 Molecular recognition of materials |
| 02/12/2013 | CA2452712C Methods for detection and quantification of analytes in complex mixtures |
| 02/07/2013 | WO2013017556A1 Method for handling product fluid flows |
| 02/07/2013 | US20130036519 Compositions and Methods for the Control of Root Lesion Nematode |
| 02/07/2013 | US20130035404 Integrated Analyses of Breast and Colorectal Cancers |
| 02/07/2013 | US20130035389 Methods for treating myelodysplastic syndrome with ezatiostat |
| 02/07/2013 | US20130035376 MCP-1 binding nucleic acids |
| 02/07/2013 | US20130035314 Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof |
| 02/07/2013 | US20130035290 Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury |
| 02/07/2013 | US20130035280 Method and means for identifying substances which inhibit IgE production |
| 02/07/2013 | US20130035257 Microfluidic arrays and methods for their preparation and use |
| 02/07/2013 | US20130035256 Chimeric Polypeptides Useful in Proximal and Dynamic High-Throughput Screening Methods |
| 02/07/2013 | US20130035255 Controlled release hybrid systems |
| 02/07/2013 | US20130035254 Diagnosis of systemic lupus erythematosus (sle) |
| 02/07/2013 | US20130035253 Methods for diagnosis, prognosis and methods of treatment |
| 02/07/2013 | US20130035252 Methods for determining a gene expression profile and for disease diagnosis |
| 02/07/2013 | US20130035251 miRNA FINGERPRINT IN THE DIAGNOSIS OF WILMS' TUMOUR |
| 02/07/2013 | US20130035250 Non-invasive method for diagnosis of prostate cancer |
| 02/07/2013 | US20130035249 Methods and compositions for detecting and treating cea-expressing cancers |
| 02/07/2013 | US20130035248 Microsporidia Detection System and Method |
| 02/07/2013 | US20130035247 Global dna hypomethylation and biomarkers for clinical indications in cancer |
| 02/07/2013 | US20130035246 Method and Apparatus for Determining a Mammal's Exposure to Chemical or Biological Agents |
| 02/07/2013 | US20130035245 Inorganic-binding peptides and quality control methods using them |
| 02/07/2013 | US20130035244 Method for Characterising a Molecule |
| 02/07/2013 | US20130035243 Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk |
| 02/07/2013 | US20130035241 Key genes, micrornas, other non-coding rnas and combination thereof for identifying and regulating the pluripotent status of cells |
| 02/07/2013 | US20130034624 Animal management |
| 02/07/2013 | US20130034540 Immune Gene Signatures in Cancer |
| 02/06/2013 | EP2553151A1 Use of induced pluripotent cells and other cells for screening compound libraries |
| 02/06/2013 | EP2553150A1 Generation of antibodies to an epitope of interest |
| 02/06/2013 | EP2514761A9 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 02/06/2013 | CN102918396A Method for identifying HLA complexes associated with adverse drug reactions |
| 02/05/2013 | US8367680 Antibacterial small molecules and methods for their synthesis |
| 02/05/2013 | CA2784463A1 Methods for treating myelodysplastic syndrome with ezatiostat |
| 01/31/2013 | WO2013016693A2 Near-infrared light-activated proteins |
| 01/31/2013 | WO2013016226A1 Quality control method for digital pathology |
| 01/31/2013 | WO2013013303A1 Ovarian markers of follicular maturity and uses thereof |
| 01/31/2013 | WO2012160519A3 Diagnostic method for determining the aggressiveness and prognosis of papillary thyroid cancer |
| 01/31/2013 | US20130030157 Rodent Combinatorial Antibody Libraries |
| 01/31/2013 | US20130030041 Near-infrared light-activated proteins |
| 01/31/2013 | US20130030035 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 01/31/2013 | US20130029926 Compositions and methods for determing cancer susceptibility |
| 01/31/2013 | US20130029878 Method for Assaying Histone Methylation Enzyme Activity |
| 01/31/2013 | US20130029877 Methods for optimizing optical mapping conditions |
| 01/31/2013 | US20130029876 Nucleic Acids and Libraries |
| 01/31/2013 | US20130029875 Templated islet cells and small islet cell clusters for diabetes treatment |
| 01/31/2013 | US20130029874 Microrna markers for recurrence of colorectal cancer |
| 01/31/2013 | US20130029873 Methods and compositions for diagnosing pulmonary fibrosis subtypes and assessing the risk of primary graft dysfunction after lung transplantation |
| 01/31/2013 | US20130029872 Array for detecting biological substance, assay system and assay method |
| 01/31/2013 | US20130029871 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
| 01/31/2013 | US20130029870 Materials and methods for diagnosis of asthma |
| 01/31/2013 | US20130029869 Molecular Profile For the Diagnosis of Metabolic Myopathies |
| 01/31/2013 | US20130029868 Methods and kits for the detection of cancer infiltration of the central nervous system |
| 01/31/2013 | US20130029867 Concentration measurement method and concentration measurement system |
| 01/31/2013 | US20130029866 Cardiomyocytes from induced pluripotent stem cells from patients and methods of use thereof |
| 01/31/2013 | US20130029865 Stromal Antigen 2 (STAG2) Compositions and Methods |
| 01/31/2013 | US20130029864 Biomarkers for alzheimer's disease |
| 01/31/2013 | US20130029863 Method for detecting microorganisms |
| 01/31/2013 | US20130029862 Clinical application utilizing genetic data for effective medication management |
| 01/31/2013 | US20130029861 Method for Detecting a Plurality of Nucleotide Polymorphisms at a Single Wavelength Using a Plurality of Oligonucleotides Modified With Fluorescent Dye Having the Same or Close Detection Wavelength |
| 01/31/2013 | US20130029860 Methods Of Diagnosing Or Treating Prostate Cancer Using The ERG Gene, Alone Or In Combination With Other Over Or Under Expressed Genes In Prostate Cancer |
| 01/31/2013 | US20130029859 Biomarker assay of neurological condition |
| 01/31/2013 | US20130029858 Method of Drug Screening through Quantitative Detection by Atomic Force Microscopy and Effective Protein Chips Development through Method Thereof |
| 01/31/2013 | US20130029857 Method for determining an allele profile of nucleic acid |
| 01/31/2013 | US20130029856 Transfer Or Interrogation Of Materials By Carrier And Receiving Devices Moving Independently And Simultaneously On Multiple Axes |
| 01/31/2013 | US20130029850 Competitive Differential Screening |
| 01/31/2013 | US20130029366 Ptp1b inhibitors |
| 01/31/2013 | US20130028899 Treatment of cancer by inhibiting activity or expression of late sv-40 factor |
| 01/31/2013 | CA2842839A1 Ovarian markers of follicular maturity and uses thereof |
| 01/29/2013 | US8361932 Detection of protease and protease activity using a single nanoscrescent SERS probe |
| 01/29/2013 | US8361385 Modular assay plates, reader systems and methods for test measurements |
| 01/29/2013 | CA2729739C Composite arrays utilizing microspheres |
| 01/24/2013 | WO2013013066A2 Methods for assessing genomic instabilities in tumors |
| 01/24/2013 | WO2013010218A1 Inhibition of clathrin |
| 01/24/2013 | US20130023565 Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their use |
| 01/24/2013 | US20130023491 Beta-cell replication promoting compounds and methods of their use |